Iloprost Concentration‐Dependently Attenuates Platelet Function and Apoptosis by Elevating PKA Activity
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Xuexiang Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cyrus Tang Medical Institute, Suzhou Medical College, Jiangsu Institute of Hematology, the First Affiliated Hospital and Collaborative Innovation Cen…. Hauptthemen laut MEDLINE: Iloprost, Apoptosis, Blood Platelets, Cyclic AMP-Dependent Protein Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key International Cooperation Projects of the National Natural Science Foundation of China, National Natural Science Foundation of China, the Key Projects of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Iloprost, a prostacyclin (PGI 2 ) analogue, stimulates the IP receptor (PTGIR) to interact with the Gsα β/γ complex, leading to the activation of adenylate cyclase, which enzyme produces the second messenger cAMP. Elevation in cAMP triggers intracellular signalling events and regulates a wide variety of cellular activities. Thus, we evaluated the effects of Iloprost on platelet function and apoptosis and in vivo haemostasis and thrombosis, as well as the underlying mechanisms. Firstly, we showed that Iloprost concentration‐dependently inhibited agonist‐induced P‐selectin exposure, integrin αIIbβ3 activation, platelet aggregation, ATP release, platelet spreading, and clot retraction. Moreover, Iloprost dose‐dependently inhibited FeCl 3 ‐induced mouse mesenteric arteriole thrombosis and markedly prolonged the tail bleeding time. Iloprost also concentration‐dependently inhibited mitochondrial membrane potential (ΔΨm) depolarisation and phosphatidylserine (PS) externalisation in platelets, thereby inhibiting platelet apoptosis, and Iloprost at concentrations lower than 2 nM inhibited only platelet apoptosis but not platelet function. Importantly, Iloprost at low doses markedly elevated peripheral platelet counts in GPIbα antibody‐induced immune thrombocytopenia (ITP). Mechanistic studies showed that Iloprost concentration‐dependently antagonised agonist‐induced decline of protein kinase A (PKA) activity and elevation of cytoplasmic Ca 2+ in platelets, thereby attenuating platelet activation and aggregation. Elevation in PKA activity inhibited dephosphorylation of proapoptotic protein BAD and reduced caspase‐3 activity, thus retarding platelet apoptosis. These data demonstrate that Iloprost dose‐dependently inhibits platelet function and apoptosis by elevating PKA activity. Moderate‐dose Iloprost impairs haemostasis and thrombosis via suppression of platelet function, and low‐dose Iloprost elevates peripheral platelet levels by inhibiting platelet apoptosis while having no effects on platelet function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cyrus Tang Medical Institute, Suzhou Medical College, Jiangsu Institute of Hematology, the First Affiliated Hospital and Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prot…
ORCID-Profile: Kesheng Dai
Förderung
- the Key International Cooperation Projects of the National Natural Science Foundation of China
- National Natural Science Foundation of China
- the Key Projects of the National Natural Science Foundation of China
- the General Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
Zitieren
APA
Wang, X., Chen, S., Wan, J., Liu, C., Yan, Y., Khan, M. S., Zhao, Z., Sun, K., Hu, R., Yang, M., Xia, Y., & Dai, K. (2025). Iloprost Concentration‐Dependently Attenuates Platelet Function and Apoptosis by Elevating PKA Activity. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70403
Vancouver
Wang X, Chen S, Wan J, Liu C, Yan Y, Khan MS, et al. Iloprost Concentration‐Dependently Attenuates Platelet Function and Apoptosis by Elevating PKA Activity. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70403
BibTeX
@article{Wang2025,
author = {Wang, Xuexiang and Chen, Shuang and Wan, Jun and Liu, Chunliang and Yan, Yan and Khan, Muhammad Shoaib and Zhao, Ziyu and Sun, Kang and Hu, Renping and Yang, Mengnan and Xia, Yue and Dai, Kesheng},
title = {Iloprost Concentration‐Dependently Attenuates Platelet Function and Apoptosis by Elevating PKA Activity},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70403}
}
EUVIMED